Skip to main content
See every side of every news story
Published loading...Updated

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN Wearable for Acute Treatment of Migraine

First and Only REN-Based Migraine Treatment Approved in China

42 Articles

WBOC 16WBOC 16
+40 Reposted by 40 other sources
Center

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine

First and Only REN-Based Migraine Treatment Approved in China

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 81% of the sources are Center
81% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Tuesday, September 30, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
Search
BlindspotLocal